-
1 Comment
Opthea Limited is currently in a long term downtrend where the price is trading 27.6% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Opthea Limited's total revenue rose by 15.1% to $314K since the same quarter in the previous year.
Its net income has dropped by 359.1% to $-35M since the same quarter in the previous year.
Finally, its free cash flow fell by 733.9% to $-12M since the same quarter in the previous year.
Based on the above factors, Opthea Limited gets an overall score of 2/5.
Sector | Healthcare |
---|---|
ISIN | AU000000OPT2 |
Industry | Biotechnology |
CurrencyCode | AUD |
Exchange | AU |
Dividend Yield | 0.0% |
---|---|
Target Price | 1.65 |
PE Ratio | 0.0 |
Market Cap | 308M |
Beta | 0.31 |
Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema (DME), as well as a first in class VEGF-C/D inhibitors for treatment with VEGF-A inhibitors to treat wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for OPT.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024